Vandetanib (Oral Route)

3 imperatives to transform health care in America. You're invited to watch it live

Free

E-newsletter

Subscribe to Housecall

Our weekly general interest
e-newsletter keeps you up to date on a wide variety of health topics.

Sign up now

Vandetanib (Oral Route)

Drug Information provided by: Micromedex

US Brand Names

  • Caprelsa

Description

Vandetanib is used to treat medullary thyroid cancer that cannot be treated with surgery or that has already spread to different parts of the body.

This medicine is available only under a registered distribution program called Vandetanib REMS (Risk Evaluation and Mitigation Strategy) Program. You will be asked to sign a form before you take this medicine. This form tells you about the benefits and risks of using this medicine. Make sure you understand what is on the form before you sign it.

Once a medicine has been approved for marketing for a certain use, experience may show that it is also useful for other medical problems. Although these uses are not included in product labeling, vandetanib is used in certain patients with the following medical conditions:

  • Non-small cell lung cancer, locally advanced or metastatic (cancer that has already spread), after failure of first- or second-line cancer treatment (chemotherapy).

This product is available in the following dosage forms:

  • Tablet
Before Using
DR603431 Portions of this document last updated: Dec. 1, 2012

Source: Drug Information provided by: Micromedex

Copyright © 2013 Thomson Healthcare Inc. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.

Advertisement


Text Size: smaller largerlarger